Both in Diagnostics
Neogen vs Myriad Genetics
Over the past year NEOG returned +92.0% and MYGN returned −27.4%; their daily moves had a correlation of 0.16.
NEOG +92.0% MYGN −27.4%Growth of $1, one year, split-adjusted
| Metric | NEOG | MYGN |
|---|---|---|
| Price | $12.08 | $5.94 |
| Market cap | $2.64B | $567.7M |
| Today | +2.16% | +1.45% |
| 1 month | −7.2% | +29.6% |
| 6 months | +30.3% | +18.0% |
| Year to date | +72.7% | −3.5% |
| 1 year | +95.7% | −26.2% |
| Revenue growth (YoY) | +6.5% | −10.5% |
| Gross margin | 47.4% | 66.6% |
| Net margin | −5.3% | −22.7% |
| P/E (TTM) | — | — |
| Price / sales | 3.0× | 0.7× |
| Net cash | -$605.6M | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 41.7% | 85.0% |
| Short % of float | 5.5% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).